The Summary Care Record (SCR) provides healthcare professionals with access to key clinical information about patients. The SCR contains information such as medications, allergies and reactions. With patient consent, additional information from a patient's general practitioner record can be included. This helps coordinate care for patients, including those with disabilities or special needs. The document discusses expanding access to the SCR to allow more care professionals to use it and better support urgent and emergency care situations.
Anne Talbot: Clinicians driving Clinical DashboardsThe King's Fund
Dr Anne Talbot, Clinical Director, Bolton Community Practice, National Clinical Lead, introduces the Urgent Care Clinical Dashboard, making the best use of data across boundaries.
Death and dying - understanding the dataMarie Curie
Phil McCarvill, Marie Curie's Head of Policy and Public Affairs, presented at 'Improving outcomes at the end of life' on 9 July, 2013 in London.
He presented on the data from Marie Curie's report 'Death and Dying' which looks at variations on the provision, spending and identification of end of life services across the country.
It draws together and analyses data from the Marie Curie End of Life Care Atlas and other sources including the Nuffield Trust study and the VOICES survey of bereaved relatives.
For more information on commissioning, have a look at our website mariecurie.org.uk/commissioning or get in touch at servicedevelopment@mariecurie.org.uk
This information sheet provides an overview of a number of ways in which we collect, analyse and publish national data and statistics.
Our information services and products are used by a range of organisations to support the commissioning and delivery of services, for research and academic studies, and to provide targeted information to patients, service users and the public.
Anne Talbot: Clinicians driving Clinical DashboardsThe King's Fund
Dr Anne Talbot, Clinical Director, Bolton Community Practice, National Clinical Lead, introduces the Urgent Care Clinical Dashboard, making the best use of data across boundaries.
Death and dying - understanding the dataMarie Curie
Phil McCarvill, Marie Curie's Head of Policy and Public Affairs, presented at 'Improving outcomes at the end of life' on 9 July, 2013 in London.
He presented on the data from Marie Curie's report 'Death and Dying' which looks at variations on the provision, spending and identification of end of life services across the country.
It draws together and analyses data from the Marie Curie End of Life Care Atlas and other sources including the Nuffield Trust study and the VOICES survey of bereaved relatives.
For more information on commissioning, have a look at our website mariecurie.org.uk/commissioning or get in touch at servicedevelopment@mariecurie.org.uk
This information sheet provides an overview of a number of ways in which we collect, analyse and publish national data and statistics.
Our information services and products are used by a range of organisations to support the commissioning and delivery of services, for research and academic studies, and to provide targeted information to patients, service users and the public.
Toward forward link interference cancellationShu Wang
A Presentation for CDG Technology Forum on Improving 3G Network Capacity, Coverage and Quality, April 20, 2006
Hyatt Regency San Francisco Airport, Burlingame, CA.
http://www.cdg.org/news/events/cdmaseminar/060420_NetworkCap/index.asp
Transforming End of Life Care in Acute Hospitals AM Workshop 5: Summary Care ...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 5: Summary Care Record and highlights from updated Toolkit for Commissioning Person Centred End of Life Care presented by Dr Robert Jeeves, Health and Social Care Information Centre and Dianne Murray, NHS England
This is an invited presentation to a British Psychological Society symposium on Prevention,which seeks to summarise key English policy trends on prevention, and help develop the BPS position on the contribution of psychological science to government policy on Prevention
Toward forward link interference cancellationShu Wang
A Presentation for CDG Technology Forum on Improving 3G Network Capacity, Coverage and Quality, April 20, 2006
Hyatt Regency San Francisco Airport, Burlingame, CA.
http://www.cdg.org/news/events/cdmaseminar/060420_NetworkCap/index.asp
Transforming End of Life Care in Acute Hospitals AM Workshop 5: Summary Care ...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 5: Summary Care Record and highlights from updated Toolkit for Commissioning Person Centred End of Life Care presented by Dr Robert Jeeves, Health and Social Care Information Centre and Dianne Murray, NHS England
This is an invited presentation to a British Psychological Society symposium on Prevention,which seeks to summarise key English policy trends on prevention, and help develop the BPS position on the contribution of psychological science to government policy on Prevention
Adrian Flowerday - Big Innovation Conversation: Operational excellenceInnovation Agency
Presentation by Adrian Flowerday, Managing Director, Docobo at the Big Innovation Conversation: Operational excellence webinar on Thursday 11 October 2018.
LTC year of care commissioning early implementer sites workshop held on 1 December 2014. Featuring Dr Martin McShane, Rob Meaker and Renata Drinkwater.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Summary Care Record Update - Robert Jeeves, NHS England
1. The NHS Summary Care Record
Supporting person centred coordinated care
2. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
• SCRs are an electronic
record of key
information from the
patient’s GP practice
• As a minimum contain
medication, allergies
and adverse reactions
Current Status
4. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
• GP practices now have
capability to enrich SCRs
with a set of additional
information - with patient
consent
• Includes individual
coded items and
associated free text as
recorded in the GP record
SCRs with additional information
Supporting person centred co-ordinated care
SCRs with additional information
Supporting person centred co-ordinated care
5. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
The Accessible Information Standard
• SCR supports commissioner and GP practices to meet the
legal duty of the Equality Act 2010; to make “reasonable
adjustments” to support disabled people. This legal duty is
“anticipatory.”
• The SCR additional information dataset includes all the
clinical codes defined in the SCCI1605 standard, as well as
other codes related to sensory, physical and learning disability,
carers, advance care planning and other preferences
• SCR uses existing information in the GP record - once patient
consent for additional information is recorded in the GP
system, then relevant codes are automatically included in SCR.
• For further information, see the Inclusion Set Overview:
SCR Inclusion Dataset Overview
6. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
The SCR:
• Provides a nationwide data sharing solution – a foundation
for access to a key set of common information that all care
settings need to access
• Complements local record sharing - complex care co-
ordination will still occur at a local level using local systems
• Provides a cost effective solution for settings that have lower
digital maturity and where local solutions are not in place
• Provides a cost effective opportunity for health communities
to accelerate local record sharing by enriching SCRs with
additional information
SCR and Local Information Sharing
7. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
Lawrence is a middle aged man with a moderate learning disability.
He has difficulty hearing, his speech can be difficult to understand
and he gets anxious with people that he does not know. His sister is
his next of kin and is very involved in his care.
SCRs with additional information
Supporting those with learning disabilities
9. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
Requirement to expand access and develop the
SCR
• National Information Board (NIB) - Personalised Health and
Care 2020 references the need to open up access more
widely and further develop the SCR
• Demand from a range of care professionals
The SCR Expert Advisory Committee
• Ensures proposals to expand the scope of the SCR are
subjected to consultation and analysis
• Membership includes representatives of patients and the
public, clinical professional bodies and Royal Colleges
• Seeks input from wider audiences and advice from relevant
expert stakeholders
Where next for the SCR?
10. www.hscic.gov.uk/scr scr.comms@hscic.gov.uk @NHSSCR
• Delivery into key areas such as community
pharmacy, scheduled care in hospitals, and
dedicated medical room in police custody
suites
• Discovery work in new environments such as
care homes and social care
Extend the
benefits to more
care
professionals
Where next for the SCR? Cont’d…
Editor's Notes
With patient consent; GP practices can enrich SCRs with additional information such as significant medical history, care plan information, patient preferences, immunisations and other relevant content including communication needs.
Resources are available to support conversations with the patient including a patient leaflet and an Easy Read leaflet, also example SCRs and user and viewer guidance.
Example?
He is quite phobic of needles but will have blood tests if local anaesthetic creams are used and someone is with him – free text against code for next slide
He is unable to stay over in hospital without close family support but his family are happy to support this - ? free text against code for next slide